Australia Restricts Risperidone Following Stroke Link

2
190

The Australian reports that their Therapeutic Goods Administration (TGA) received new data from drug company Janssen-Cilag, the developers of risperidone, “indicating a more than fivefold higher risk of ‘cerebrovascular adverse events’ — stroke or transient ischaemic ­attack — in patients with vascular or mixed dementia on risperidone.”

Article →

 

2 COMMENTS

  1. This should not be surprising, as Risperdal and all the “atypical antipsychotics” cause heart issues in adults of whatever age. I’m glad Australia is finally doing something about it and hope the USA follows suit, but it should have been done long before. This is not new news.

    Report comment

LEAVE A REPLY